Kaken Pharmaceutical Co., Ltd. (4521.T) - Quarterly Income Statement

Home
4521.T
Financials

3869 (JPY) • At close November 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1	2011 Q4	2011 Q3	2011 Q2	2011 Q1	2010 Q4	2010 Q3	2010 Q2	2010 Q1	2009 Q4	2009 Q3	2009 Q2	2009 Q1	2008 Q4	2008 Q3	2008 Q2
Revenue Numbers are in millions	18,254	17,359	18,514	18,021	18,150	17,411	18,754	18,622	18,197	18,326	20,120	19,135	18,453	17,897	20,293	18,719	18,070	19,056	25,008	22,835	22,335	21,583	25,063	23,386	24,135	21,541	27,031	24,893	24,967	23,026	26,786	25,951	26,228	23,787	30,458	27,340	27,633	22,740	26,923	22,768	21,464	21,931	23,306	22,442	21,270	20,242	23,282	22,742	20,781	20,641	23,661	22,409	21,283	20,346	23,214	21,083	21,788	19,101	23,582	21,318	21,024	18,802	23,022	20,610
Cost of Revenue Numbers are in millions	8,202	8,680	8,375	8,356	8,094	8,418	8,578	8,275	8,157	8,769	9,101	8,411	8,177	8,793	9,381	8,217	7,682	8,901	10,573	9,772	9,507	9,591	10,798	9,810	10,167	9,921	11,585	10,379	10,520	10,628	11,630	11,089	11,192	11,358	12,805	11,576	11,841	10,663	12,562	10,910	10,625	10,873	11,877	11,500	10,919	10,869	11,858	11,551	10,683	10,745	12,046	11,328	10,809	10,806	11,756	10,688	10,818	10,126	12,096	11,081	10,815	10,016	12,066	10,489
Gross Profit Numbers are in millions	10,052	8,679	10,139	9,665	10,056	8,993	10,176	10,347	10,040	9,557	11,019	10,724	10,276	9,104	10,912	10,502	10,388	10,155	14,435	13,063	12,828	11,992	14,265	13,576	13,968	11,620	15,446	14,514	14,447	12,398	15,156	14,862	15,036	12,429	17,653	15,764	15,792	12,077	14,361	11,858	10,839	11,058	11,429	10,942	10,351	9,373	11,424	11,191	10,098	9,896	11,615	11,081	10,474	9,540	11,458	10,395	10,970	8,975	11,486	10,237	10,209	8,786	10,956	10,121
Gross Profit Ratio Numbers are in millions	0.551	0.5	0.548	0.536	0.554	0.517	0.543	0.556	0.552	0.521	0.548	0.56	0.557	0.509	0.538	0.561	0.575	0.533	0.577	0.572	0.574	0.556	0.569	0.581	0.579	0.539	0.571	0.583	0.579	0.538	0.566	0.573	0.573	0.523	0.58	0.577	0.571	0.531	0.533	0.521	0.505	0.504	0.49	0.488	0.487	0.463	0.491	0.492	0.486	0.479	0.491	0.494	0.492	0.469	0.494	0.493	0.503	0.47	0.487	0.48	0.486	0.467	0.476	0.491
Reseach & Development Expenses Numbers are in millions	2,998	4,041	2,764	3,138	2,600	9,479	1,980	2,300	2,030	2,385	2,027	2,143	1,865	1,874	1,595	1,694	1,573	1,677	1,407	1,725	1,609	2,517	2,036	2,129	3,579	2,374	2,134	1,808	1,836	1,465	1,358	1,728	1,899	1,491	1,427	1,557	1,408	2,809	1,432	1,754	1,620	1,799	1,768	1,880	1,598	1,519	1,588	1,734	1,461	1,796	1,713	1,617	1,466	1,780	1,440	2,006	1,626	2,048	1,830	2,019	1,975	2,461	1,757	1,854
General & Administrative Expenses Numbers are in millions	0	31	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,211	308	328	353	688	302	339	341	982	325	392	334	895	314	353	335	868	296	661	704	444	792	726
Selling & Marketing Expenses Numbers are in millions	0	3,967	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	735	255	214	266	731	311	236	191	793	333	273	308	837	361	303	278	833	328	266	297	1,003	411	355
SG&A Numbers are in millions	4,303	3,998	4,015	4,307	4,162	3,909	4,010	3,895	3,953	3,739	4,139	3,966	3,989	4,391	4,151	4,057	3,783	4,168	4,339	4,300	4,513	4,563	4,682	4,739	4,740	5,252	4,941	5,019	4,962	4,905	4,968	5,108	5,039	5,175	4,980	4,997	5,150	4,950	5,123	5,383	5,133	4,946	563	542	619	1,419	613	575	532	1,775	658	665	642	1,732	675	656	613	1,701	624	927	1,001	1,447	1,203	1,081
Other Expenses Numbers are in millions	1	25	15	15	2	172	44	69	49	57	22	19	32	38	12	12	7	57	43	11	-1	42	25	16	2	29	42	17	4	18	10	15	4	14	16	3	14	-97	-88	-96	-145	-138	-130	-119	-119	-74	-193	-119	-59	-89	-68	-108	-52	-123	-87	-111	-86	-94	-87	-134	-83	-65	-84	-93
Operating Expenses Numbers are in millions	7,302	8,039	6,779	7,444	6,761	13,387	5,990	6,194	5,982	6,380	6,168	6,108	5,852	6,264	5,746	5,750	5,355	6,075	5,746	6,026	6,119	7,303	6,717	6,868	8,317	7,831	7,073	6,827	6,796	6,643	6,326	6,835	6,937	6,969	6,407	6,554	6,556	8,059	6,555	7,137	6,751	7,018	6,958	7,061	6,868	6,897	9,655	5,679	5,238	7,233	5,750	5,644	5,350	7,212	5,454	6,011	5,461	7,728	5,814	5,946	5,872	7,995	5,828	5,886
Operating Income Numbers are in millions	2,750	640	3,361	2,219	3,293	-4,396	4,185	4,153	4,056	3,175	4,853	4,615	4,421	2,839	5,167	4,751	5,031	4,080	8,688	7,039	6,705	4,689	7,547	6,709	5,647	3,790	8,371	7,686	7,649	5,754	8,830	8,026	8,097	5,457	11,246	9,209	9,234	4,020	7,805	4,721	4,085	4,042	4,472	3,880	3,478	2,476	1,768	5,512	4,860	2,663	5,865	5,437	5,124	2,328	6,004	4,384	5,509	1,247	5,672	4,291	4,337	791	5,128	4,235
Operating Income Ratio Numbers are in millions	0.151	0.037	0.182	0.123	0.181	-0.252	0.223	0.223	0.223	0.173	0.241	0.241	0.24	0.159	0.255	0.254	0.278	0.214	0.347	0.308	0.3	0.217	0.301	0.287	0.234	0.176	0.31	0.309	0.306	0.25	0.33	0.309	0.309	0.229	0.369	0.337	0.334	0.177	0.29	0.207	0.19	0.184	0.192	0.173	0.164	0.122	0.076	0.242	0.234	0.129	0.248	0.243	0.241	0.114	0.259	0.208	0.253	0.065	0.241	0.201	0.206	0.042	0.223	0.205
Total Other Income Expenses Net Numbers are in millions	-379	-64	201	-12	156	-1,428	227	68	-50	-3,747	169	166	232	135	150	128	453	329	-129	-299	176	11	182	1	132	-115	157	15	129	-66	400	-41	88	-32	94	-32	110	-136	-1,732	-107	-47	-147	-55	-148	-29	-103	2,646	-1,492	-1,490	120	-1,773	-1,388	-1,482	-323	-1,459	-1,380	-1,519	-413	-1,407	-1,292	-1,507	-333	-1,992	-1,417
Income Before Tax Numbers are in millions	2,371	576	3,562	2,207	3,451	-5,824	4,412	4,221	4,008	-572	5,021	4,781	4,655	2,975	5,317	4,880	5,485	4,410	8,559	6,738	6,885	4,700	7,731	6,709	5,782	3,675	8,530	7,701	7,780	5,690	9,229	7,986	8,187	5,428	11,341	9,177	9,346	3,883	6,074	4,614	4,040	3,894	4,415	3,734	3,453	2,374	4,414	4,020	3,370	2,783	4,092	4,049	3,642	2,005	4,545	3,004	3,990	834	4,265	2,999	2,830	458	3,136	2,818
Income Before Tax Ratio Numbers are in millions	0.13	0.033	0.192	0.122	0.19	-0.335	0.235	0.227	0.22	-0.031	0.25	0.25	0.252	0.166	0.262	0.261	0.304	0.231	0.342	0.295	0.308	0.218	0.308	0.287	0.24	0.171	0.316	0.309	0.312	0.247	0.345	0.308	0.312	0.228	0.372	0.336	0.338	0.171	0.226	0.203	0.188	0.178	0.189	0.166	0.162	0.117	0.19	0.177	0.162	0.135	0.173	0.181	0.171	0.099	0.196	0.142	0.183	0.044	0.181	0.141	0.135	0.024	0.136	0.137
Income Tax Expense Numbers are in millions	617	-775	955	650	940	-2,115	1,227	1,165	1,100	125	1,497	1,422	1,292	504	1,610	1,474	1,664	595	2,552	2,017	2,058	1,172	2,324	1,904	1,747	1,491	2,540	2,295	2,317	1,656	2,693	2,336	2,390	4,419	3,689	2,994	3,046	1,365	2,108	1,605	1,410	1,590	1,582	1,344	1,245	762	1,651	1,506	1,267	1,157	2,042	1,622	1,462	800	1,778	1,187	1,566	206	1,675	1,189	1,124	149	1,275	1,162
Net Income Numbers are in millions	1,754	1,350	2,607	1,558	2,510	-3,709	3,185	3,057	2,907	-697	3,525	3,359	3,362	2,471	3,708	3,406	3,820	3,816	6,007	4,721	4,826	3,528	5,407	4,805	4,035	2,184	5,991	5,405	5,463	4,034	6,537	5,650	5,796	1,009	7,651	6,183	6,300	2,517	3,966	3,009	2,630	2,304	2,833	2,391	2,207	1,611	2,764	2,514	2,102	1,626	2,049	2,427	2,180	1,206	2,766	1,816	2,424	628	2,590	1,809	1,706	308	1,860	1,656
Net Income Ratio Numbers are in millions	0.096	0.078	0.141	0.086	0.138	-0.213	0.17	0.164	0.16	-0.038	0.175	0.176	0.182	0.138	0.183	0.182	0.211	0.2	0.24	0.207	0.216	0.163	0.216	0.205	0.167	0.101	0.222	0.217	0.219	0.175	0.244	0.218	0.221	0.042	0.251	0.226	0.228	0.111	0.147	0.132	0.123	0.105	0.122	0.107	0.104	0.08	0.119	0.111	0.101	0.079	0.087	0.108	0.102	0.059	0.119	0.086	0.111	0.033	0.11	0.085	0.081	0.016	0.081	0.08
EPS Numbers are in millions	46.32	35.65	68.84	41.29	66.98	-98.98	84.99	81.46	76.89	-18.43	93.17	88.46	87.76	64.5	96.79	87.52	98.18	98.05	154.35	118.99	121.65	88.92	136.28	119.27	100.16	54.21	148.7	132.37	133.81	98.8	160.1	136.5	140.05	24.38	184.85	149.26	152.09	60.76	95.74	71.35	62.38	54.63	67.17	55.45	51.2	37.36	64.1	56.96	47.64	36.84	46.42	53.09	47.68	26.34	57.54	37.78	50.44	13.06	52.76	36.85	34.75	6.27	34.83	31.01
EPS Diluted Numbers are in millions	46.32	35.65	68.84	41.29	66.98	-98.98	84.99	81.46	76.89	-18.43	93.17	88.46	87.76	64.5	96.79	87.52	98.18	98.05	154.35	118.99	121.65	88.92	136.28	119.27	100.16	54.21	148.7	132.37	133.81	98.8	160.1	136.5	140.05	24.38	184.85	149.26	152.09	60.76	95.74	71.35	62.38	54.63	67.17	55.45	51.2	37.36	64.1	56.96	47.64	36.84	46.42	53.09	47.68	26.34	57.54	37.78	50.44	13.06	52.76	36.85	34.75	6.27	34.83	31.01
EBITDA Numbers are in millions	3,439.25	1,314	3,586	2,239	3,492	-4,218	4,425	4,228	4,335	3,225	5,036	4,635	4,663	2,881	5,340	4,765	5,253	4,122	8,905	7,034	6,902	4,721	7,723	6,724	5,819	3,797	8,549	7,707	7,817	5,754	9,000	8,027	8,221	5,453	11,354	9,218	9,367	3,928	7,803	4,630	4,060	3,911	4,413	3,766	3,474	2,406	1,713	5,396	4,803	2,575	5,798	5,333	5,072	2,894	6,588	4,879	5,955	1,791	6,202	4,758	4,834	1,385	5,672	4,154
EBITDA Ratio Numbers are in millions	0.188	0.076	0.194	0.124	0.192	-0.242	0.236	0.227	0.238	0.176	0.25	0.242	0.253	0.161	0.263	0.255	0.291	0.216	0.356	0.308	0.309	0.219	0.308	0.288	0.241	0.176	0.316	0.31	0.313	0.25	0.336	0.309	0.313	0.229	0.373	0.337	0.339	0.173	0.29	0.203	0.189	0.178	0.189	0.168	0.163	0.119	0.074	0.237	0.231	0.125	0.245	0.238	0.238	0.142	0.284	0.231	0.273	0.094	0.263	0.223	0.23	0.074	0.246	0.202

Kaken Pharmaceutical Co., Ltd.

TSE:4521.T Add to watchlist

TSE:4521.T